Special instrument for treating hypertrophic cardiomyopathy through pulsed field ablation
By designing a dedicated pulsed field ablation device for hypertrophic cardiomyopathy, employing a dual-catheter magnetic suction design and a sterile cannula heating element, the problems of complex operation and damage risk of existing devices are solved, achieving precise nanoscale ablation and improving surgical safety.
Patent Information
- Application Number
- CN202411885267.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-20
- Publication Date
- 2026-06-23
AI Technical Summary
The existing pulsed field ablation devices lack dedicated treatment equipment for hypertrophic cardiomyopathy, which makes the operation complex, difficult to promote widely, and poses a risk of damage to normal myocardial conduction bundles.
A specialized device for pulsed field ablation therapy of hypertrophic cardiomyopathy was designed. It adopts a dual-catheter push-pull release elastic circular radial magnetic suction design, combined with a sterilization sleeve and heating element, to ensure precise positioning and disinfection of the ablation area and simplify the operation process.
This technique enables precise nanoscale perforation ablation of hypertrophic myocardium, avoiding ventricular septal rupture and damage to normal myocardium, improving surgical safety and ease of operation, and promoting the widespread application of pulsed field ablation therapy.